Italy lifts ban on Novartis flu vaccines

Italian health authorities on Friday lifted a ban on the sale of flu vaccines made by Swiss pharmaceutical giant Novartis, saying that tests had shown they were not a health risk.

"The decision was made possible due to in-depth checks which were carried out as a precaution to protect public health," Italy's public agency for pharmaceuticals AIFA said in a statement.

Italy's health ministry last month ordered a ban on Aggripal, Fluad and Influpozzi after white particles were seen in syringes carrying the vaccines.

Austria, Canada, Germany and Switzerland subsequently also ordered temporary bans although some have since been lifted.

Novartis has said it is confident on the "safety and efficacy" of its vaccines.

Related Stories

Germany orders recall of some Novartis flu shots

date Oct 25, 2012

(AP)—German authorities ordered a recall Thursday of some batches of Novartis flu vaccine as a precautionary measure after the company reported the appearance of small particles in the manufacturing process.

EU drug agency: License 2 swine flu vaccines

date Sep 25, 2009

(AP) -- The European Union's drug regulator recommended Friday that two swine flu vaccines be licensed in the 27-nation bloc to ensure their availability before the start of the normal flu season.

Recommended for you

FDA clears drug for leading form of cystic fibrosis

date 6 hours ago

Federal health officials have approved a new combination drug for the most common form of cystic fibrosis, the debilitating inherited disease that causes internal mucus buildup, lung infections and early death.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.